By the FL Innovation News editorial team · Florida Living
Peptide therapy is moving from niche wellness circles into wider conversations about preventive care, recovery, metabolic health, and healthy aging. Across Florida, clinics are seeing more patients ask about peptides as part of a more personalized approach to care. At the same time, regulators are paying closer attention to how these products are marketed, sourced, and used, especially when they are sold online without proper medical oversight.
A growing category in wellness and preventive care
Peptides are short chains of amino acids. In the body, many act as signaling molecules that help regulate important functions. In medicine, some peptide-based drugs are FDA-approved for specific uses, while many other peptide products being promoted online or on social media are not approved and do not have the same level of safety, quality, or effectiveness review.
In markets like Tampa Bay and St. Petersburg, interest has grown as more patients look for proactive, physician-guided options rather than waiting until a problem becomes harder to treat. Recovery, body composition, skin quality, hormone support, and general performance are common reasons patients start asking questions about peptide therapy, but the right plan depends on the person, their history, and proper follow-up. That is why experienced providers are putting more focus on labs, screening, and ongoing monitoring rather than offering peptides as a one-size-fits-all fix.
“At our clinic, we are seeing more patients come in already informed and asking better questions,” said Nadia Kaminskaya, founder of Sunshine Wellness and Aesthetics. “They are not just looking for something trendy. They want to understand what they are using, where it comes from, and whether it actually fits their health goals.”
More attention from regulators and the medical community
As peptides become more visible, so do the concerns around unapproved products and unsafe sourcing. The FDA has recently warned that some products sold online as semaglutide, tirzepatide, retatrutide, and other peptide-related drugs have been unlawfully marketed to consumers, including products falsely labeled “for research purposes” or “not for human consumption” even when they were clearly being sold for people to use. The agency has also warned about fraudulent compounded GLP-1 products with false labeling and even labels naming pharmacies that, based on FDA information, did not actually make the products.
That matters because these products are not just a paperwork issue. When a peptide comes from an unverified seller, patients may be dealing with unknown potency, poor sterility controls, contamination, counterfeit labeling, or ingredients that do not match what is on the vial. FDA guidance on certain compounded bulk substances also points to peptide-related risks such as impurities, aggregation, immunogenicity, and limited human safety data for some products.
The danger of black-market and “research use only” peptides
One of the biggest concerns in this space is the black market for so-called research peptides. These products are often sold through websites, chat groups, or social media pages using language meant to dodge regulation, but the FDA has been clear that products marketed this way can still be unlawful and dangerous when they are effectively being sold for human use. Unapproved drugs do not go through the same FDA review for safety, effectiveness, and manufacturing quality as approved products.
Patients may assume that a vial labeled “research only” is simply a cheaper version of something legitimate. In reality, there may be no reliable way to confirm what is actually in the product, whether it was made under sterile conditions, or whether the dose is accurate. With injectable products especially, that gap creates real risk. Even beyond GLP-1s, FDA has identified safety concerns with some peptide substances proposed for compounding because peptide impurities and characterization issues can affect safety.
“Patients want support, not guesswork,” Kaminskaya said. “The issue is not just whether someone can get a peptide online. The real question is whether they should, and whether they know what they are actually getting.”
Why working with a trusted provider matters
For patients considering peptide therapy, medical oversight is not a luxury. It is a safety issue. A trusted provider can review medical history, current medications, goals, and lab work before starting treatment. They can also help patients understand what is evidence-based, what is still experimental, what side effects to watch for, and whether a peptide is even appropriate in the first place.
That also means using regulated sourcing channels. While compounded medications can play a role in care in certain situations, the FDA continues to stress that compounded drugs are not FDA-approved and should not be treated as interchangeable with approved products. The agency has also taken action as national GLP-1 shortages eased, noting that semaglutide and tirzepatide shortages have been resolved and continuing to warn about non-FDA-approved mass-marketed alternatives.
A reputable clinic should be able to explain where a treatment comes from, how dosing is determined, what follow-up looks like, and what outcomes are realistic. That is a very different standard from a website that takes payment first and leaves patients to figure the rest out on their own.
Florida’s role in the wellness market
Florida remains a strong market for wellness, aesthetics, and preventive care, driven by population growth, a large self-pay health market, and a culture that values both performance and lifestyle. Tampa Bay and South Florida have seen growth in clinics offering services that go beyond the traditional sick-care model, including hormone support, IV therapy, medical weight programs, and peptide-based care. As more providers enter the space, education, patient experience, and clinical judgment are becoming bigger points of difference.
What patients should know before starting peptide therapy
Patients who are considering peptides should ask a few basic questions before moving forward:
- Is it being prescribed and monitored by a licensed medical provider?
- Is there a clear treatment plan, including labs, dosing, follow-up, and side-effect review?
- Is the product coming through a legitimate, regulated channel, not a “research use only” seller or anonymous online source?
- Am I being promised unrealistic results without any discussion of risk?
The safest approach is to view peptide therapy as one part of a broader care plan, not a shortcut. In many cases, the best outcomes come from combining medical guidance with nutrition, sleep, movement, lab review, and regular check-ins.
Looking ahead
Interest in peptides will likely keep growing as patients look for more customized options in wellness and preventive medicine. But growth in this category will also bring more scrutiny around quality, legality, and marketing claims. For clinics, the job is not just to offer what is popular. It is to make sure patients have access to thoughtful care, trusted sourcing, and honest education.
“Peptides can be a useful tool when they are used the right way,” Kaminskaya said. “But this is not an area where patients should be left to sort through internet hype, fake labels, or black-market products on their own.”
About Sunshine Wellness and Aesthetics
Sunshine Wellness and Aesthetics is a St. Petersburg-based clinic focused on personalized wellness and preventive care. The clinic offers services including peptide therapy, hormone support, lab testing, IV therapy, and aesthetic treatments, with an emphasis on education, access, and continuity of care.
Founded by Nadia Kaminskaya, Sunshine Wellness and Aesthetics was built for patients who want more clarity, structure, and support in their health plan. Rather than relying on guesswork or online trends, the clinic focuses on provider-guided care that helps patients better understand what they are using, why they are using it, and how it fits into their long-term goals.
Cited Resources
- U.S. Food and Drug Administration (FDA). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss - U.S. Food and Drug Administration (FDA). Clinical Pharmacology Considerations for Peptide Drug Products.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-pharmacology-considerations-peptide-drug-products - U.S. Food and Drug Administration (FDA). Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks.
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks - U.S. Food and Drug Administration (FDA). FDA Launches “Green List” to Protect Americans from Illegal Imported GLP-1 Drug Ingredients.
https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients - National Center for Biotechnology Information (NCBI). Peptide Therapeutics: Overview and Applications.
https://www.ncbi.nlm.nih.gov/books/NBK562260/ - World Health Organization (WHO). Substandard and Falsified Medical Products.
https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products
Medical disclaimer: This article is general information about health topics and is not medical advice. It is not a substitute for a conversation with your own clinician, who can advise on what is appropriate for your circumstances.
